SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Calixa Therapeutics, Inc. Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections